Centrica PLC Transaction in Own Shares
11 March 2025 - 6:00PM
RNS Regulatory News
RNS Number : 0833A
Centrica PLC
11 March 2025
|
Transactions in own shares
Centrica plc
11 March
2025
Centrica plc announces that it
purchased on 10 March 2025 (through Merrill Lynch International)
4,014,334 Centrica plc ordinary shares of 6
14/81 pence each at a price of 146.36 pence
per share. The purchased shares will be held as treasury shares.
Such purchase was effected pursuant to the extension of the
Company's 2024-25 buyback programme announced on 27 December 2024
and in accordance with the non-discretionary share repurchase
agreement entered into with Merrill Lynch International as also
announced on 27 December 2024, which agreement was subsequently
amended as announced on 3 March 2025.
Since 3 March 2025, Centrica has
purchased 10,080,525 ordinary shares at a cost (excluding dealing
and associated costs) of £14,875,701.01.
Following the above purchase,
Centrica plc holds 460,144,052 ordinary shares in treasury, and has
5,032,963,162 ordinary shares in issue (excluding treasury
shares).
In accordance with Article 5(1)(b) of
Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in
force in the UK and as amended by the Market Abuse (Amendment) (EU
Exit) Regulations 2019), detailed information about the individual
purchases made by Merrill Lynch International is set out
below.
Transaction details: Centrica plc ordinary shares of 6
14/81 pence each
|
|
|
|
|
|
|
|
|
|
Merrill Lynch
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares
purchased:
|
|
|
|
|
|
|
|
Volume weighted average price paid
per share:
|
|
|
|
|
Disaggregated information
The table attached contains detailed
information of the individual trades made by Merrill Lynch International, as part of
the buyback programme.
Click on, or paste the following link
into your web browser, to view the associated PDF
document.
http://www.rns-pdf.londonstockexchange.com/rns/0833A_1-2025-3-10.pdf
END
Enquiries:
Investors and Analysts
E: ir@centrica.com
Centrica
plc is listed on the London Stock Exchange (CNA)
Registered
Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4
5GD
Registered
in England & Wales number: 3033654
Legal
Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN
number: GB00B033F229
|
|
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
POSGZGMFRGLGKZM
Centrica (LSE:CNA)
Historical Stock Chart
From Feb 2025 to Mar 2025
Centrica (LSE:CNA)
Historical Stock Chart
From Mar 2024 to Mar 2025
